Project Grant NH28CE003284
- Schools Together Allowing No Drugs (STAND) received a $670,621 Project Grant from the Appalachian Regional Commission (ARC) under the Appalachian Area Development program (CFDA 23.002) awarded October 1, 2025, with completion anticipated by September 30, 2028. The grant funds workforce training and comprehensive substance abuse prevention education targeting high-risk populations in Tennessee, including LGBTQ+ youth, rural communities, and socioeconomically disadvantaged groups. STAND delivers...
- This $1,300,000 Project Grant award from the U.S. Department of Justice's Bureau of Justice Assistance (CFDA 16.838 - Comprehensive Opioid, Stimulant, and Substance Use Program) aims to address the opioid epidemic in Cumberland County, North Carolina. The funding supports a comprehensive, whole-person, harm reduction approach through a partnership with the Cumberland County Department of Public Health, Fayetteville Police Department, NC Harm Reduction Coalition, and the Cumberland-Fayetteville...
- This Project Grant award, with a total funding amount of $957,600.00, was provided by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279). The grant will be used by Drexel University to develop a novel framework for community-directed research approaches that seek to reduce intersectional and intergenerational inequities in commercial tobacco use among Black and Latinx adult sexual and gender minorities in Philadelphia. Key activities...
- The Multi-Cultural Community Alliance, through Encouraging Leaders, was awarded a $702,864 Project Grant from the Department of Justice Office of Justice Programs Office of Juvenile Justice and Delinquency Prevention under the Opioid Affected Youth Initiative (CFDA 16.842) program. The funding will support strategies to strengthen collaboration among youth, parents, schools, public safety, public health and ethnic community-based organizations in Minneapolis to provide community-based...
- Summary The National Institute on Drug Abuse (NIDA) awarded $2.31 million to the University of California, San Diego under the Drug Use and Addiction Research Programs (CFDA 93.279) beginning August 1, 2025, through April 30, 2030. This Project Grant funds a hybrid Type I implementation trial titled "Breaking Barriers: Innovating HIV Elimination with Social Network Strategies and Routine Substance Use Screening," which addresses the intersecting epidemics of HIV and substance use...
- This $1,000,000 Project Grant award from the U.S. Department of Justice's Bureau of Justice Assistance under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838) will enable Floyd County Fiscal Court and its partners to implement a comprehensive substance use prevention, diversion, and treatment program for youth under 18 in Floyd County, Kentucky. Key program activities include: 1) Developing and implementing court-based substance use diversion services and...
- The San Francisco Department of Public Health (SFDPH) was awarded a $1,600,000 Project Grant by the Bureau of Justice Assistance (BJA) under the Comprehensive Opioid, Stimulant, and other Substances Use Program (CFDA 16.838). The grant will fund the implementation of the "Data-Driven Health Systems Change for Prevention" (DHSCP) program, which aims to develop a comprehensive, collaborative, and innovative Overdose Fatality Review (OFR) process in San Francisco. Key expected outcomes...
- Grant Award Summary The Johnston Prevention Coalition received $180,000 in Project Grant funding from the Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Substance Abuse Prevention under the Substance Abuse and Mental Health Services Projects of Regional and National Significance program (CFDA 93.243) for the period September 30, 2025 through September 29, 2029. The award funds implementation of the Sober Truth On Preventing Underage Drinking (STOP) Act framework to...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $1.09M Project Grant to the Research Foundation for Mental Hygiene, Inc. (New York State Psychiatric Institute) on March 1, 2026, to develop and pilot E-ConnectYA, a system-level intervention designed to improve substance use disorder (SUD) and mental health (MH) treatment engagement and reduce overdose and suicide risk among criminal legal system-involved young adults (YACL). The five-year project,...
- Summary The National Institute on Drug Abuse (NIDA) awarded a $6.62 million Cooperative Agreement on August 15, 2025, to the University of California, San Diego to establish the "Responding to the Increase in Substance Use, HIV, HCV, and Overdose in New England" (RISE-NE) cohort study under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds a five-year prospective cohort study recruiting 1,200 people who use drugs (PWUD), including 15% living with HIV, across...
PREVENTING AND REDUCING SUBSTANCE USE AMONG BLACK, LATINX AND LGBTQ+ YOUTH IN STATEN ISLAND - THE TYSA COALITION WAS FORMED IN 2011 TO ADDRESS ALARMING RATES OF ALCOHOL AND OPIOID USE AMONG STATEN ISLAND YOUTH. IN THE DECADE SINCE ITS FORMATION, TYSA HAS USED THE COLLECTIVE IMPACT MODEL TO ALIGN PARTNERS AND MAXIMIZE IMPACT RESULTING IN THE REDUCTIONS IN YOUTH PRESCRIPTION DRUG USE, AS MEASURED BY THE YOUTH DEVELOPMENT SURVEY, AS WELL AS SHIFTS IN COMMUNITY NORMS REGARDING STIGMA, AN INCREASE IN SUBSTANCE USE DISORDER RESOURCES TO THE COMMUNITY, AND HAS CONTRIBUTED TO POLICY CHANGE. HOWEVER, THESE GREAT STRIDES HAVE NOT REACHED ALL POPULATIONS WITH THE SAME LEVEL OF IMPACT. DATA DEMONSTRATES THAT OPIOID USE IS HIGHER AMONG BLACK, LATINX AND LGBTQ+ YOUTH AS COMPARED TO WHITE, HETEROSEXUAL AND CISGENDER YOUTH. ADDITIONALLY, THE USE OF METHAMPHETAMINES, A DRUG TYPICALLY ASSOCIATED WITH THE MID-WEST, IS ALSO MUCH HIGHER IN THESE COMMUNITIES AND THERE HAVE BEEN ALMOST NO TARGETED INTERVENTIONS TO ADDRESS THE DRUG. ADVERSE CHILDHOOD EXPERIENCES- SUCH AS PARENTAL INCARCERATION, CHILD ABUSE AND NEGLECT, AND PARENTAL SUBTANCE USE- IN ADDITION TO ISSUES OF ECONOMIC DISTRESS AND MINORITY STRESS ARE CONTRIBUTING TO THESE POOR HEALTH OUTCOMES IN BLACK, LATINX & LGBTQ+ YOUTH. CONSEQUENTLY, TYSA IS SEEKING CARA FUNDING TO IMPLEMENT THE BELOW, COMPREHENSIVE, ENVIRONMENTAL STRATEGIES TO ACHIEVE THE TWO AMBITIOUS GOALS OUTLINED BY CDC:GOAL 1: L REDUCE OPIOID, METHAMPHETAMINE, AND PRESCRIPTION DRUG USE/MISUSE AMONG YOUTH. OBJECTIVE 1: BY JUNE, 2022, TYSA WILL REACH 100,000 COMMUNITY MEMBERS (YOUTH AND ADULTS) THROUGH SOCIAL MARKETING CAMPAIGNS AND VIRTUAL/IN-PERSON SKILL-BUILDING WORKSHOPS AS MEASURED BY SOCIAL MEDIA ANALYTICS AND WORKSHOP ATTENDANCE. STRATEGY 1: TYSA WILL PROVIDE INFORMATION TO COMMUNITY MEMBERS ABOUT THE PREVALENCE AND RISKS OF OPIOID AND METHAMPHETAMINES USE AMONG BLACK, LATINX AND LGBTQ+ YOUTHGOAL ONE:STRATEGY 2: ENHANCE THE SKILLS OF PARENTS, SCHOOL PERSONNEL, AND COMMUNITY ORGANIZATIONS TO BUILD CAPACITY TO PREVENT AND INTERVEN E IN OPIOID AND METHAMPHETAMINE USE GOAL 2: CHANGE THE CULTURE AND CONTEXT REGARDING ACCEPTABILITY OF YOUTH OPIOID, METHAMPHETAMINE, AND/OR PRESCRIPTION DRUG USE/MISUSE. OBJECTIVE 1: BY JUNE 2022, TYSA WILL INCREASE COMMUNITY DIALOGUE ABOUT OPIOID, METHAMPHETAMINE, AND OTHER DRUG USE AND INCREASE YOUTH PARTICIPATION IN POSITIVE ACTIVITIES, AS MEASURED BY FOCUS GROUP DATA ON COMMUNITY NORMS AND YOUTH ATTENDANCE.STRATEGY 1: CHANGE SOCIAL CONSEQUENCES OF METHAMPHETAMINE USE THROUGH THE DEVELOPMENT OF A COMMUNITY-LED SOCIAL NORMS CAMPAIGNSSTRATEGY 2: CHANGE CONSEQUENCES BY INCENTIVIZING PARTICIPATION OF BLACK, LATINX & LGBTQ+ YOUTH IN THE TYSA COALITION AND OTHER DRUG FREE ACTIVITIES TYSA IS COMMITTED TO PARTNERSHIPS WITH THE COMMUNITY AND WILL USE THE STRATEGIC PREVENTION FRAMEWORK AND ITS EXISTING VAST PARTNERSHIPS WITH DIVERSE INDIVIDUALS AND ORGANIZATIONS TO ENSURE THAT THIS PROJECT IS CO-DEVELOPED WITH BLACK, LATINX AND LGBTQ+ YOUTH AND THEIR FAMILIES, AND IS CULTURALLY RESPONSIVE.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $0 | 11/10/25 | ||
| Not listed | $50.0k | 6/23/25 | ||
| Not listed | $50.0k | 6/23/25 | ||
| Not listed | $50.0k | 5/24/24 | ||
| Not listed | $50.0k | 5/24/24 |